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Abstract: How can we advance the hypodermic syringe solving or at least dramatically 
improving its inherited problems without affecting the main purpose of the device – 
injecting and extracting liquid and gas substances to and from places difficult to reach?  
The answer is quite simple – it has to be a syringe that has no plunger and, therefore, no 
opening in the barrel for the plunger to operate.  That would construct an enclosed and 
completely sealed system capable of preserving sterility, vacuum or any original 
conditions, working in both directions (injection and extraction), providing for the 
shelf-life of the chemical inside to match its molecular stability, and simplifying 
shipping, storage, logistics and packaging, reducing, at the same time, the human error.  
No more short-shelf-life chemicals, squeezing out air, and the poisonous vapors in the 
environment.  That’s a tall order is not it.  That would open doors for unlimited new 
opportunities in medical research and development while the other industries would start 
knocking on our doors.  The level of healthcare would improve greatly and rapidly while 
the cost of it would go down due to this revolution in hypodermic injection.Now, it looks 
as the answer was found by Mr. Boris Zubry (New Wave Medical, L.L.C.) in his US 
Patent # 7,255,684 (Magnetic Plungerless Injection System).  This patent covers 
proprietary single-dosage cartridges and a magnetic actuator.  The principal benefits of 
this system are: 1) lower cost for manufacturers, providers and end-users, 2) improved 
packaging, storage, shipping and logistics, 3) extended shelf life of pharmaceutical 
products and 4) enhanced safety and regulatory compliance.  All this combined answers 
many, if not all, questions raised above.   
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Parenteral Medication is a well known method, other than that of ingestion, for drug delivery and is being 
quite widely used since thousands of year ago. This could be employed as, IV, IM, Sub-Q, or mucosal and 
it holds a permanent position among healing techniques.  There are three major advantages of injection:  
Rapid drug delivery; 
It produces direct results; 
Drugs are absorbed directly into the bloodstream. 
 
Injections are mostly used: 
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When patient is in the state that makes any other drug deliveries difficult; 
To avoid and, therefore, not irritate the digestive system of the patient; 
To deliver a precise dosage of medication to a targeted area.  
 
Parenteral drugs are currently filled into multi-dosage vials and single-dosage glass ampoules for use 
with regular syringes, a cartridge for a reusable syringe, and/or a pre-filled syringe system.   
 
The hypodermic syringe is a medical instrument used for injecting Parenteral Medication into either 
muscles or bloodstream (medical application) and is one of the oldest known medical devices.  It was 
described by ancient Greeks and Romans more then two thousand years ago.  The hypodermic syringe 
consists of a small graduated tube (barrel) with a close-fitting piston (plunger assembly) and a nozzle onto 
which a hollow needle can be fitted.  The barrel has an opening on one end for the plunger to move freely in 
and out and on the other end for the fluid to pass into the needle.  Needle connects syringe barrel and the 
recipient body. 
 
 
Hypodermic syringes are actually pumps commonly employed to transfer some relatively small amounts 
of liquids to or from otherwise inaccessible (internal organs of the living organism or aggressive 
environments, for example) areas.  This instrument could be made out of wood, paper, and glass, plastic, 
metal or any other materials strong enough to hold fluids for a short period of time.  It operates on the 
principle of suction by filling the barrel with the fluid material at the opening when the plunger is drawn out, 
and pressure by expelling the fluid material when the plunger is depressed.  The process of administering a 
substance with a syringe that has a needle attached is called an injection.  Regular syringes could be used for 
extraction and injection.  The word syringe comes from the Greek “syrinx”, which means "tube". 
 
NEEDLE SYRINGES AND PARENTERAL DRUGS. 
 
Syringes are commonly applied in medicine in conjunction with hypodermic needles for injections of 
liquids into body tissues, or for their removal from the body.  They may also be used as parts of medical and 
scientific devices, containers, or scientific apparatus such as in certain types of chromatography.  Syringes 
may also be incorporated when cooking meat to enhance flavor and texture by injecting juices inside the 
meat, and in baking to inject filling inside a pastry.  Syringes have also been used for refilling ink cartridges 
with ink and for injecting glue and special fillings into cracks and openings during construction and 
restoration processes.  The injection of gas into a blood vessel is extremely undesirable, as it may cause a 
gas embolism leading often to the fatal results.  Prevention of embolisms by removing air from the syringe 
is the source of the familiar image of holding a syringe upside down, tapping it, and expelling a small 
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amount of liquid before an injection into the bloodstream.  That operation guarantees no air or any other gas 
in the barrel and in the needle of the syringe. 
 
Over the years, hypodermic syringes have transformed from the barrel made out of a hardened piece of 
bamboo with a hollow fishbone attached to it all the way to a very sophisticated single use safety syringe 
with a retractable needle and the precise measurement for the injected material.  The present syringes are 
made out of class, metals and plastics and designed mainly for single use.  The most common trend today is 
a variation on a single use pre-filled syringe with a safety needle.  Yes, we can see the tremendous change in 
appearance, quality of manufacturing, safety and the simplicity of use of the syringe.  More and more 
medication can be administered at the home setting by the end-user without participation of the medical 
professional.  Multiple use, single use, safety, cartridge, pen, multi-chamber and variations of all above 
syringes are available today on the syringe market.  Industry is still pushing it toward the easy solution that 
would incorporate simple design; user friendly application; home injections; low cost of drug, syringe and 
shipping, and the better safety, compliance and the waste management.  
But how much did syringe really change over the years?  As we know, drug longevity mostly depends on 
three factors: light, temperature and air.  The issue of light is solved by additives and colored materials used 
for packaging (vials, ampoules and syringes).  Temperature is controlled through cold storage and air is 
removed by vacuum or displaced by purging Nitrogen.  For thousands of years this device is still operated 
through drawing and depressing a plunger and, therefore, the opening in the barrel is a must.  No matter 
what materials are used and how well it all done, the opening is there.  This opening is an attractive 
invitation for air, impurities, germs and the bacteria to squeeze in and attack the drug inside affecting its 
potency and often results of its administration.  Given a little time, the substance inside the syringe would 
spoil before its stability runs out if it was stored properly.  Even the best made pre-filled syringes are not 
desirable for the long storage of medication due to shelf-life limitations stated above.  Therefore, a dosage, 
which may come in an ampoule and a vial (the decades of drug shelf-live are limited only by the drug 
stability and/or by opening of the storage vessel and introducing air and other impurities) and in a pre-filled 
and/or cartridge syringe (the drug shelf-life, usually less then a year, is limited by the quality of the fill and 
the seal between the piston and the wall of the syringe in the opening left for the plunger to operate).  In 
short, in order to administer the drug, we need a syringe and a dosage in a vial or an ampoule (long shelf-life) 
or a variation of the pre-filled syringe (short shelf-life).  Sounds expensive, complicated and much is left 
open for the human error.  And, what do we do with an expired medication?  There is a whole industry built 
just around that issue.  The less shelf-life of the drug the more has to be disposed of and destroyed.  How 
much does it add to the cost of the healthcare?  How much of so needed funds we have to spend there 
instead of putting it into research and new developments?  How many sicknesses and the lost productivity 
of the healthcare professionals can be attributed to breathing in medication while squeezing the air out the 
syringe before injection?  Not even EPA can tell us that?  We can create the most sophisticated safety 
needles and protect people from sticking but how can we protect the environment from the used syringes 
leaking the leftover medication from the opening at the end for the plunger to operate?  The syringe disposal 
containers mostly protect from sharp objects inside and not the poisonous vapors of the remains of 
medication.  These vapors mix inside the containers building concoctions we cannot even predict, and that 
leaks from millions of such containers into environment.  And, the present syringes cannot really handle 
gasses and what if we need that?  Ordering syringes, vials and ampoules, logistics, shipping and storage of 
all components adds another pretty penny to the cost of healthcare and who pays for it but us, the end-users. 
So, the question remains the same: how can we advance the hypodermic syringe solving or at least 
dramatically improving problems stated above without affecting the main purpose of the device – injecting 
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and extracting liquid and gas substances to and from places difficult to reach?  The answer is quite simple – 
it has to be a syringe that has no plunger and, therefore, no opening in the barrel for the plunger to operate.  
That would construct an enclosed and completely sealed system capable of preserving sterility, vacuum or 
any original conditions, working in both directions (injection and extraction), providing for the shelf-life of 
the chemical inside to match its molecular stability, and simplifying shipping, storage, logistics and 
packaging, reducing, at the same time, the human error.  No more short-shelf-life chemicals, squeezing out 
air, and the poisonous vapors in the environment.  That’s a tall order is not it.  That would open doors for 
unlimited new opportunities in medical research and development while the other industries would start 
knocking on our doors.  The level of healthcare would improve greatly and rapidly while the cost of it 
would go down due to this revolution in hypodermic injection. 
Now, It looks as the answer was found by Mr. Boris Zubry (New Wave Medical, L.L.C.) in his US Patent 
# 7,255,684 (Magnetic Plungerless Injection System).  This patent covers proprietary single-dosage 
cartridges and a magnetic actuator.  The principal benefits of this system are: 1) lower cost for 
manufacturers, providers and end-users, 2) improved packaging, storage, shipping and logistics, 3) 
extended shelf life of pharmaceutical products and 4) enhanced safety and regulatory compliance.  All this 
combined answers many, if not all, questions raised above.   
The Magnetic Plungerless Injection System is a hand-held apparatus with a magnetically driven piston 
capable of displacing, moving and transferring liquid or gas through a cartridge chamber and into a sterile 
needle for injections.  The device can also be applied to extract liquid or gas substances.  This apparatus 
works on the principle that a magnetic field penetrates glass and plastic walls of the cartridge.  A magnet 
located on the outside of the cartridge wall and a ferrous piston positioned inside of the cartridge create 
strong coupling with the ferrous piston repeating the movements of the magnet.  Movement of the piston in 
one direction generates insertion of liquid and/or gas substances and movement in the other direction 
produces extraction.  This device incorporates storage for solid, gas and liquid substances and an injection 
system for gasses and liquids at the same time.  
 
HOW DOES THE DEVICE SOLVE THOSE PROBLEMS? 
 
A trigger mechanism, designed to use magnetic energy, moves a piston inside the fully sealed cartridge 
to inject and/or withdraw, eliminating plunger assembly and creating a fully preserved system with a solid 
back wall.  Dosages come in a completely sealed cartridge (solid back wall) that is placed into a trigger 
mechanism (injector). Dosages now have an increased shelf life limited only by the stability of the drug that 
could be estimated (in the ideal conditions) in years, if not decades. This is achieved though introduction of 
vacuum and/or Nitrogen during the filling process. This device is a combination of the syringe and a storage 
vessel at the same time. Reduced cost and storage space; simplified shipping and logistics achieved through 
eliminating of vials and ampoules and modification of the syringe filling and assembly process. Also larger 
batches of medication could be produced. The syringe features combine: pre-filled syringes, usage of empty 
and filled cartridges due to the piston movement in both direction; long drug shelf life cartridges, 
simplification of the drug manufacturing process, less packaging, shipping, handling, storage and logistics. 
Also it could be used for liquid, powder and gas chemicals. This syringe would increase safety and decrease 
medical waste dramatically moving injection closer to the green approach.  
 
VERSATILITY 
 
Small, compact, inexpensive and easy to store and use design and construction. The trigger mechanism 
(injector) and the cartridge are light weight and can be used for liquid, gas and powder drugs and chemicals; 
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Works in both directions and, therefore, capable of injection and extraction of drugs, chemicals, body 
fluids and samples of air, gases, chemicals and the bacteriological substances; 
This syringe will standardize industry even more reducing the unnecessary varieties of syringes and 
cutting the cost of injection even further.  It will reduce waste due to elimination of the plunger that is 
accountable for a half of the waste of the disposable syringe. Increased safety due to reduction in possible 
human errors in dosages.  Also due to usage vacuum and Nitrogen there would be no air bubble.   
Ways it will benefit the healthcare industry:   
Magnetic syringe saves money due to the less expensive manufacturing of the drug and the cartridge, 
usage, cost of logistics, storage, disposal and transportation;  
Syringes will be pre-filled which would save critical time, assures accuracy and total compliance of 
medication (decreases human error and protects environment);  
Magnetic syringe’s weight and size would contribute dramatically to the life-saving medical service. It 
decreases medical waste because it has no plunger and uses less packaging. Dual function of the completely 
sealed cartridges is that they can be used for collection of samples in cases of chemical and biological 
incidents 
 
Now, lets discuss a few issues in greater details 
1)  Lows cost for manufacturers, providers and the end-users:  
Manufacturing of Parenteral Drugs presently is done in batches.  Batch size is determent through the 
amount of sales; shelf life, expiration date of medication and equipment capability.  You run a batch and 
then you have to clean the equipment, do the batch paperwork, inspections and preparation for the next 
batch.  It could be another batch of the same medication.  Considering that modern equipment is quite high 
speed downtime could be greater than manufacturing time.  You may run your machinery for 4 hours to 
produce the whole month worth of a specific drug and than clean it and do the paperwork for the whole shift.  
If, for example, you could group up 12 batches (1 year of sales) and run the machines for the whole week 
and than do the cleaning for a shift, your productivity would increase dramatically and manufacturing cost 
go down.  But pharmaceutical companies don’t do that now because they don’t want to store drug that may 
go out of date.  Shelf life is too short. 
Now, if we could increase shelf life that we would not care about storage for a year or so, we could solve 
that problem and low our manufacturing cost dramatically increasing batches.  The answer is in that 
vacuum.  The vacuum technique is well known and well used only: you can’t apply vacuum to an ampoule 
due to the heat seal at the end of the process and when you apply vacuum to a multi-dose vial you lose it 
with the first injection.  In the case of the pre-filled syringe (cartridge) vacuum may suck the plunger in 
breaking the seal in the opening at the end for plunger to operate.  The plungerless syringe solves that 
problem allowing for vacuum and, therefore, extended shelf life and expiration dates of medication. 
Providers would benefit even more than in one area.  Manufacturers would shift some of their savings to 
the providers making it less expensive.  Drugs would be pre-filled and with a long expiration date and could 
be purchased in larger numbers and stored.  Purchasing in larger numbers would decrease cost even more.  
There would be no need for additional syringes.  Disposal would become less expensive because instead of 
disposal of a vial and a syringe one would dispose only the cartridge.  Cartridge is about a half weight of the 
syringe.  The future disposal cost would be about a half of the present disposal cost.  There would be no 
danger of contamination of drugs used and the environment due to the sealed system.  Less waste would 
enter environment protecting it from the contaminants.  And, much more. 
End-users would be able to employ more self injections at home without going to the medical 
professionals.  Sealed cartridges could be easily shipped by mail and injected in accordance with 
instructions.       
2)  Improves storage, shipping and logistics: 
Storage of just cartridges becomes very easy.  You store only cartridges and no syringes or vials and 
ampoules.  Shipping of pre-filled syringes is done presently in specially designed containers.  Leakage and 
contamination is high.  Losses are high.  Vibration may damage the seal at the plunger opening of the 
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syringe.  Many companies have to manufacture or fill drug locally in order to avoid the shipping issues and 
that means low runs and the high cost.  Logistics are affected because you don’t order syringes anymore.      
3)   Extended shelf life of pharmaceutical products:  
Extended shelf life leads to larger batches and, therefore, low manufacturing cost; longer storage and less 
complicated shipping; sales in larger quantities; drug availability in remote areas; less waste and better 
environment; better safety and compliance and unlimited possibilities for new research.  In short, we would 
have a much less expensive solution for Parenteral Drugs and injections and with much better quality.  
Some would say: “Well, where is this wonderful syringe?  It sounds great.  I want to use it.”  And the 
answer is: the Plungerless Magnetic Injection System is still in development due to financial issues.  If 
you have any ideas, any good idea would be considered.  New Wave Medical L.L.C.: 721-329-0189.   
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